Prevalence of high-risk human papillomavirus infections in healthy Saudi women attending gynecologic clinics in the western region of Saudi Arabia

Annals of Saudi Medicine

Volumn 33, Issue 1, 2013, Pages 13-17

  Bondagji, Nabeel Salem ^a   Gazzaz, Faten Salah ^b   Sait, Khalid ^a   Abdullah, Layla ^b  

^a Aziz University   (Saudi Arabia)

^b KING ABDULAZIZ UNIVERSITY   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; GROUPS BY AGE; HIGH RISK PATIENT; HUMAN; HUMAN PAPILLOMAVIRUS DNA TEST; MAJOR CLINICAL STUDY; PAPILLOMAVIRUS INFECTION; PREVALENCE; PRIORITY JOURNAL; SAUDI ARABIA; WART VIRUS;

ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; CERVIX UTERI; DNA, VIRAL; EARLY DETECTION OF CANCER; FEASIBILITY STUDIES; FEMALE; HUMANS; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PREVALENCE; PROSPECTIVE STUDIES; SAUDI ARABIA; TUMOR VIRUS INFECTIONS; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 84873887920     PISSN: 02564947     EISSN: 09754466     Source Type: Journal    
DOI: 10.5144/0256-4947.2013.13     Document Type: Article

References (38)

1. Jemal A, Bray F, Center M, Ferlay J, Ward E, Forman D.Global cancer statistics. CA CANCER J CLIN 2011; 61:69- 90.
2. Saudi Cancer Registry cancer incidence and survival reports Saudi Arabia 2007. National Saudi Cancer Registry. Riyadh (KSA): Ministry of Health. Available at: http://www.scr.org.sa/reports/SCR2007.pdf.
3. El Dosoky M, Ismail N, Dagastani M. Preinvasive cervical carcinoma in Saudi Arabia. Lancet 1995 Mar 11; 345(8950): 650.
4. Manji M. Cervical cancer screening program in Saudi Arabia: action is overdue. Ann Saudi Med 2000 Sep-Nov; 20(5-6): 355-357.
5. Kitchener HC, Symonds P. Detection of cervical intraepithelial neoplasia in developing countries. Lancet 1999 Mar 13; 353(9156): 856-857.
6. Zur Hausen H. Human papillomaviruses in the pathogenesis of anogenital cancer. Virology 1991 Sep; 184(1): 9-13.
7. Bosch FX, Manos MM, Munoz N, et al. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group. J Natl Cancer Inst 1995 June 7; 87(11): 796-802.
8. Walboomers JM, Jacobs MV, Manos MM, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999 Sep; 189(1): 12-19.
9. Munoz N, Bosch FX, de Sanjose S, et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 2003 Feb 6; 348(6): 518-527.
10. US Food and Drug Administration. FDA News. FDA approves expanded use of HPV test. www.fda.gov/bbs/topics/news/2003/new00890.html Accessed July 14, 2003.
11. Cuzick J, Arbyn M, Sankaranarayanan R, Tsu V, Ronco G, Mayrand MH, Dillner J, et al. Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries. Vaccine. 2008 Aug 19; 26 Suppl 10:K29-K41.
12. Sherris J, Wittet S, Kleine A, et al. Evidencebased, alternative cervical cancer screening approaches in low-resource settings. Int Perspect Sex Reprod Health. 2009; 35:147-154.
13. Sankarana rayanan R, Nene BM, Shastri SS, et al. HPV screening for cervical cancer in rural India. N Engl J Med. 2009; 360: 1385-1394.
14. Solomon D, Davey D, Kurman R, Moriarty A, O'Connor D, Prey M et al. The 2001 Bethesda System: terminology for reporting results of cervical cytology. JAMA 2002; 287:2114-2119.
15. Parkin DM, Almonte M, Bruni L, Clifford G, Curado MP, Pineros M. Burden and trends of typespecific human papil lomavirus infections and related diseases in the Latin America and Caribbean an region. Vaccine. 2008; 26(suppl 11):L1-L15.
16. Mathew A, Geoge PS. Trends in incidence and mortality rates of squamous cell carcinoma and adenocarcinoma of cervix- worldwide. Asia n Pac J Cancer Prev. 2009; 10:645-650.
17. Kahn JA. HPV vaccination for the prevention of cervical intraepithelial neoplasia. N Engl J Med 2009; 361:271.
18. Bruni L, Diaz M, Castellsague X, Ferrer E, Bosch FX, de Sanjose S.Cervical human papillomavirus prevalence in 5 continents: meta-analysis of 1 million women with normal cytological findings. J Infect Dis. 2010 Dec 15; 202(12):1789-99.
19. Alsbeih G, Ahmed R, Al-Harbi N, Venturina LA, Tulbah A, Balaraj K. Prevalence and genotypes' distribution of human papillomavirus in invasive cervical cancer in Saudi Arabia. Gynecol Oncol. 2011 Jun 1; 121(3):522-6.
20. Al-Badawi I, Al-Suwaine A, Al-Aker M, Asaad L, Alaidan A. Tulbah A, et al. Detection and Genotyping of Human Papilloma Virus in Cervical Cancer Specimens from Saudi Patients. Int J Gynaecol Cancer: 2011; 21: 907-910.
21. Wu RF, Dai M, Qiao YL, Clifford GM, Liu ZH, Arslan A, et al. Human Papillomavirus infection in women in Shenzhen City, People's Republic of China, a population typical of recent Chinese urbanisation. Int J Cancer 2007, 121:1306-1311.
22. ASCUS-LSIL Traige Study (ALTS) Group. A randomized trial on the management of low-grade squamous intraepithelial lesion cytology interpretations. Am J Obstet Gynecol 2003; 188:1393.
23. Cuzick J, Clavel C, Petry KU, et al. Overview of the European and North American studies on HPV testing in primary cervical cancer screening. Int J Cancer 2006; 119:1095.
24. Kim JJ, Wright TC, Goldie SJ. Cost-effectiveness of human papillomavirus DN A testing in the United Kingdom, The Netherlands, France, and Italy. J Natl Cancer Inst 2005; 97:888.
25. Denny LA, Wright TC Jr. Human papillomavirus testing and screening. Best Pract Res Clin Obstet Gynaecol 2005; 19:501.
26. Koliopoulos G, Arbyn M, Martin-Hirsch P, et al. Diagnostic accuracy of human papillomavirus testing in primary cervical screening: a systematic review and meta-analysis of non-randomized studies. Gynecol Oncol 2007; 104:232.
27. Mayrand MH, Duarte-Franco E, Rodrigues I, et al. Human papillomavirus DN A versus Papanicolaou screening tests for cervical cancer. N Engl J Med 2007; 357:1579.
28. Ronco G, Giorgi-Rossi P, Carozzi F, Confortini M, Dalla Palma P, Del Mistro A et al. Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomized controlled trial. Lancet Oncol. 2010 Mar; 11(3):249-57.
29. Sankaranarayanan R, Nene BM, Shastri SS, Jayant K, Muwonge R, Budukh AM et al. HPV screening for cervical cancer in rural India. N Engl J Med. 2009 Apr 2;360(14):1385-94.
30. Al-Muammar T, Al-Ahdal MN, Hassan A, Kessie G, Dela Cruz DM, Mohamed GE. Human papilloma virus-16/18 cervical infection among women attending a family medical clinic in Riyadh. Ann Saudi Med. 2007 Jan-Feb; 27(1):1-5.
31. Gazzaz FS. Molecular Testing of Human Papillomavirus (HPV ) in Cervical Specimens. Saudi Med J 2007; Vol. 28 (12): 1810-1818.
32. El-All HS, Refaat A, Dandash K.Prevalence of cervical neoplastic lesions and Human Papilloma Virus infection in Egypt: National Cervical Cancer Screening. Infect Agent Cancer. 2007 Jul 4; 2:12.
33. Mroueh AM, Seoud MA, Kaspar HG, Zalloua PA.Prevalence of genital human papillomavirus among Lebanese women Eur J Gynaecol Oncol. 2002; 23(5):429-32.
34. Dunne EF, Sternberg M, McQuillan G, Swan DC, Patel SS, Markowitz LE . Prevalence of HPV infection among females in the United States. JAMA 2007 Feb 28; 297(8):813-819.
35. Li LK, Dai M, Clifford GM, Yao WQ, Arslan A, Li N, Shi JF, et al. Human Papillomavirus infection in Shenyang City, People's Republic of China: A population-based study. Br J Cancer 2006, 95:1593-1597.
36. Kjaer S, Hogdall E, Frederiksen K, Munk C, van den Brule A, Svare E, et al. The absolute risk of cervical abnormalities in high-risk human papillomavirus- positive, cytologically normal women over a 10-year period. Cancer Res 2006; 66:10630.
37. Khan MJ, Castle PE, Lorincz AT, Wacholder S, Sherman M, Scott DR et al. The elevated 10- year risk of cervical precancerous and cancer in women with human papillomavirus (HPV ) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice. J Natl Cancer Inst 2005; 97:1072.
38. Datta SD, Koutsky LA, Ratelle S, Unger ER, Shlay J, McClain T et al. Human papillomavirus infection and cervical cytology in women screened for cervical cancer in the United States, 2003-2005. Ann Intern Med. 2008 Apr 1; 148(7):493-500.